Literature DB >> 8253833

Determination of initiation of DNA replication before and after nuclear formation in Xenopus egg cell free extracts.

Y Kubota1, H Takisawa.   

Abstract

Xenopus egg extracts prepared before and after egg activation retain M- and S-phase specific activity, respectively. Staurosporine, a potent inhibitor of protein kinase, converted M-phase extracts into interphase-like extracts that were capable of forming nuclei upon the addition of sperm DNA. The nuclei formed in the staurosporine treated M-phase extract were incapable of replicating DNA, and they were unable to initiate replication upon the addition of S-phase extracts. Furthermore, replication was inhibited when the staurosporine-treated M-phase extract was added in excess to the staurosporine-treated S-phase extract before the addition of DNA. The membrane-depleted S-phase extract supported neither nuclear formation nor replication; however, preincubation of sperm DNA with these extracts allowed them to form replication-competent nuclei upon the addition of excess staurosporine-treated M-phase extract. These results demonstrate that positive factors in the S-phase extracts determined the initiation of DNA replication before nuclear formation, although these factors were unable to initiate replication after nuclear formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253833      PMCID: PMC2290898          DOI: 10.1083/jcb.123.6.1321

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  40 in total

1.  Injected nuclei in frog oocytes: fate, enlargement, and chromatin dispersal.

Authors:  J B Gurdon
Journal:  J Embryol Exp Morphol       Date:  1976-12

Review 2.  The nuclear lamins. A multigene family of proteins in evolution and differentiation.

Authors:  G Krohne; R Benavente
Journal:  Exp Cell Res       Date:  1986-01       Impact factor: 3.905

3.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

4.  Formation in vitro of sperm pronuclei and mitotic chromosomes induced by amphibian ooplasmic components.

Authors:  M J Lohka; Y Masui
Journal:  Science       Date:  1983-05-13       Impact factor: 47.728

5.  A polypeptide domain that specifies migration of nucleoplasmin into the nucleus.

Authors:  C Dingwall; S V Sharnick; R A Laskey
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

6.  Initiation of DNA replication in nuclei and purified DNA by a cell-free extract of Xenopus eggs.

Authors:  J J Blow; R A Laskey
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

7.  Regulation of nuclear envelope precursor functions during cell division.

Authors:  G P Vigers; M J Lohka
Journal:  J Cell Sci       Date:  1992-06       Impact factor: 5.285

8.  Replication occurs at a nucleoskeleton.

Authors:  D A Jackson; P R Cook
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

9.  Roles of cytosol and cytoplasmic particles in nuclear envelope assembly and sperm pronuclear formation in cell-free preparations from amphibian eggs.

Authors:  M J Lohka; Y Masui
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Induction of nuclear envelope breakdown, chromosome condensation, and spindle formation in cell-free extracts.

Authors:  M J Lohka; J L Maller
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  31 in total

1.  Xenopus Cut5 is essential for a CDK-dependent process in the initiation of DNA replication.

Authors:  Yoshitami Hashimoto; Haruhiko Takisawa
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

2.  A novel ring-like complex of Xenopus proteins essential for the initiation of DNA replication.

Authors:  Yumiko Kubota; Youhei Takase; Yasunori Komori; Yoshitami Hashimoto; Toshiaki Arata; Yoichiro Kamimura; Hiroyuki Araki; Haruhiko Takisawa
Journal:  Genes Dev       Date:  2003-05-01       Impact factor: 11.361

3.  The N-terminal noncatalytic region of Xenopus RecQ4 is required for chromatin binding of DNA polymerase alpha in the initiation of DNA replication.

Authors:  Kumiko Matsuno; Maya Kumano; Yumiko Kubota; Yoshitami Hashimoto; Haruhiko Takisawa
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Regulation of replication licensing by acetyltransferase Hbo1.

Authors:  Masayoshi Iizuka; Tomoko Matsui; Haruhiko Takisawa; M Mitchell Smith
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

5.  Xenopus Cdc45-dependent loading of DNA polymerase alpha onto chromatin under the control of S-phase Cdk.

Authors:  S Mimura; H Takisawa
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

6.  Cdc6 protein causes premature entry into S phase in a mammalian cell-free system.

Authors:  K Stoeber; A D Mills; Y Kubota; T Krude; P Romanowski; K Marheineke; R A Laskey; G H Williams
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

7.  Licensing of DNA replication by a multi-protein complex of MCM/P1 proteins in Xenopus eggs.

Authors:  Y Kubota; S Mimura; S Nishimoto; T Masuda; H Nojima; H Takisawa
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

8.  The RLF-M component of the replication licensing system forms complexes containing all six MCM/P1 polypeptides.

Authors:  P Thömmes; Y Kubota; H Takisawa; J J Blow
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

9.  Site-specific initiation of DNA replication in Xenopus egg extract requires nuclear structure.

Authors:  D M Gilbert; H Miyazawa; M L DePamphilis
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replication.

Authors:  Alessia Balestrini; Claudia Cosentino; Alessia Errico; Elizabeth Garner; Vincenzo Costanzo
Journal:  Nat Cell Biol       Date:  2010-04-11       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.